Zai Lab Announces Upcoming Presentations in November Investor Conferences

Rhea-AI Summary

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a global biopharmaceutical company, announced participation in several upcoming virtual investor conferences in November 2021. They will present at the Goldman Sachs Asia Pacific Healthcare Forum on November 15, the BioCentury-BayHelix China Healthcare Summit from November 16-19, and the Jefferies London Healthcare Conference with a presentation available starting November 18. Investors can access webcasts and replays through Zai Lab's website.

SHANGHAI, SAN FRANCISCO and CAMBRIDGE, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that management from Zai Lab will be presenting at the following upcoming virtual investor conferences in November:

Goldman Sachs Asia Pacific Healthcare Forum 2021
Panel discussion: Monday, November 15, 2021 at 9:00 a.m. HKT

The 8th BioCentury-BayHelix China Healthcare Summit
Panel discussion: Several pre-record and live-streaming videos available beginning on Tuesday, November 16, 2021 through Friday, November 19, 2021

Jefferies London Healthcare Conference
Presentation: Pre-record video available beginning on Thursday, November 18, 2021 at 8:00 a.m. GMT through Friday, November 19, 2021 at 5:00 p.m. GMT

Webcast link of Jefferies London Healthcare Conference will be available under “Events & Presentations” in the “Investor Relations” section of Zai Lab’s website. An archived replay will be available for 30 days following the event.

About Zai Lab

Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is a patient-focused, innovative, commercial-stage, global biopharmaceutical company focused on developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders and infectious disease. To that end, our experienced team has secured partnerships with leading global biopharmaceutical companies in order to generate a broad pipeline of innovative marketed products and product candidates. We have also built an in-house team with strong product discovery and translational research capabilities and are establishing a pipeline of proprietary product candidates with global rights. Our vision is to become a leading global biopharmaceutical company, discovering, developing, manufacturing and commercializing our portfolio in order to impact human health worldwide.

For additional information about the company, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.

For more information, please contact:

ZAI LAB CONTACTS:

Investor Relations: Ron Aldridge / Lina Zhang
+1 (781) 434-8465 / +86 136 8257 6943
ronald.aldridge@zailaboratory.com / lina.zhang@zailaboratory.com
Media: Danielle Halstrom / Xiaoyu Chen
+1 (215) 280-3898 / +86 185 0015 5011
danielle.halstrom@zailaboratory.com / xiaoyu.chen@zailaboratory.com 

Zai Lab Limited

FAQ

When is Zai Lab presenting at the Goldman Sachs Asia Pacific Healthcare Forum?

Zai Lab will present at the Goldman Sachs Asia Pacific Healthcare Forum on November 15, 2021.

What dates will Zai Lab participate in the BioCentury-BayHelix China Healthcare Summit?

Zai Lab will participate in the BioCentury-BayHelix China Healthcare Summit from November 16 to November 19, 2021.

When will Zai Lab's presentation at the Jefferies London Healthcare Conference be available?

Zai Lab's presentation at the Jefferies London Healthcare Conference will be available starting on November 18, 2021, at 8:00 a.m. GMT.

How can investors access Zai Lab's conference presentations?

Investors can access Zai Lab's conference presentations and replays through the 'Events & Presentations' section of their Investor Relations website.

What is Zai Lab's focus as a biopharmaceutical company?

Zai Lab focuses on developing therapies for oncology, autoimmune disorders, and infectious diseases.